UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Translational PK/PD and the first-in-human dose selection of a PD1/IL15: an engineered recombinant targeted cytokine for cancer immunotherapy

Frontiers in pharmacology, 2024-06, Vol.15, p.1380000

2024

Volltextzugriff (PDF)

Hyperactive Ras in developmental disorders and cancer

Nature reviews. Cancer, 2007-04, Vol.7 (4), p.295-308

2007

Volltextzugriff (PDF)

Suppression of leukemia development caused by PTEN loss

Proceedings of the National Academy of Sciences - PNAS, 2011-01, Vol.108 (4), p.1409-1414

2011

Volltextzugriff (PDF)

Biochemical and Functional Characterization of Germ Line KRAS Mutations

Molecular and Cellular Biology, 2007-11, Vol.27 (22), p.7765-7770

2007

Volltextzugriff (PDF)

714 PD1 x TGFβR2 bispecifics selectively block TGFβR2 on PD1-positive T cells, promote T cell activation, and elicit an anti-tumor response in solid tumors

Journal for immunotherapy of cancer, 2020-11, Vol.8 (Suppl 3), p.A756-A756

2020

Volltextzugriff (PDF)

Germline Mutations in Components of the Ras Signaling Pathway in Noonan Syndrome and Related Disorders

Cell cycle (Georgetown, Tex.), 2006-08, Vol.5 (15), p.1607-1611

2006

Volltextzugriff (PDF)

Deregulated Ras signaling in developmental disorders: new tricks for an old dog

Current opinion in genetics & development, 2007-02, Vol.17 (1), p.15-22

2007

Volltextzugriff (PDF)

Targeting the MYC and PI3K pathways eliminates leukemia-initiating cells in T-cell acute lymphoblastic leukemia

Cancer research (Chicago, Ill.), 2014-12, Vol.74 (23), p.7048-7059

2014

Volltextzugriff (PDF)

IL-15/IL-15Rα-Fc-Fusion Protein XmAb24306 Potentiates Activity of CD3 Bispecific Antibodies through Enhancing T-Cell Expansion

Molecular cancer therapeutics, 2024-09, Vol.23 (9), p.1305-1316

2024

Volltextzugriff (PDF)

Germline KRAS mutations cause Noonan syndrome

Nature genetics, 2006-03, Vol.38 (3), p.331-336

2006

Volltextzugriff (PDF)

Methods for PTEN in Stem Cells and Cancer Stem Cells

Methods in molecular biology (Clifton, N.J.), 2016, Vol.1388, p.233

2016

Volltextzugriff (PDF)

Abstract 5565: Potency-reduced IL15/IL15Rα heterodimeric Fc-fusions display enhanced in vivo activity through increased exposure

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13_Supplement), p.5565-5565

2018

Volltextzugriff (PDF)

Abstract 3633: Anti-SSTR2 × anti-CD3 bispecific antibody induces potent killing of human tumor cells in vitro and in mice, and stimulates target-dependent T cell activation in monkeys: A potential immunotherapy for neuroendocrine tumors

Cancer research (Chicago, Ill.), 2017-07, Vol.77 (13_Supplement), p.3633-3633

2017

Volltextzugriff (PDF)

Abstract 1639: Combination of PD1 blockade and T cell costimulation by bispecific antibodies promotes human T cell activation and proliferation

Cancer research (Chicago, Ill.), 2017-07, Vol.77 (13_Supplement), p.1639-1639

2017

Volltextzugriff (PDF)

Abstract 2080: LAG3-targeted IL15/IL15Rα-Fc (LAG3 x IL15) fusion proteins for preferential TIL expansion

Cancer research (Chicago, Ill.), 2022-06, Vol.82 (12_Supplement), p.2080-2080

2022

Volltextzugriff (PDF)

Abstract B12: Co-inhibition of PI3K and Myc pathways is synthetic lethal to PTEN null T-ALL leukemia-initiating cells

Molecular cancer therapeutics, 2013-05, Vol.12 (5_Supplement), p.B12-B12

2013

Volltextzugriff (PDF)

Hyperactive Ras in developmental disorders and cancer

Nature reviews. Cancer, 2007-07, Vol.7 (7)

2007

Volltextzugriff (PDF)

Erratum: Hyperactive Ras in developmental disorders and cancer

Nature reviews. Cancer, 2007-07, Vol.7 (7), p.564-564

2007

Volltextzugriff (PDF)

Mutation analysis in Costello syndrome: functional and structural characterization of the HRAS p.Lys117Arg mutation

Human mutation, 2008-02, Vol.29 (2), p.232-239

2008

Volltextzugriff (PDF)

De novo HRAS and KRAS mutations in two siblings with short stature and neuro-cardio-facio-cutaneous features

Journal of medical genetics, 2007-07, Vol.44 (7), p.e84-e84

2007

Volltextzugriff (PDF)

Biochemical and functional analysis of Ras pathway mutations in myeloid leukemia and developmental disorders

Schubbert, Suzanne

2007

Volltextzugriff (PDF)

Erratum: Corrigendum: Germline KRAS mutations cause Noonan syndrome

Nature genetics, 2006-05, Vol.38 (5), p.598-598

2006

Volltextzugriff (PDF)

Corrigendum: Germline KRAS mutations cause Noonan syndrome

Nature genetics, 2006-05, Vol.38 (5), p.598-598

2006

Volltextzugriff (PDF)

De novo HRAS and KRAS mutations in two siblings with short stature and neuro-cardio-facio-cutaneous features

BMJ case reports, 2009, Vol.2009 (jan21 1), p.bcr0720080550-bcr0720080550

2009

Volltextzugriff (PDF)

Genotyping and drug response: use of single nucleotide polymorphisms (SNPs) versus haplotypes to predict albuterol efficacy

AAPS PharmSci, 2001, Vol.3 (3), p.1-2

Schubbert, S

2001

Volltextzugriff (PDF)

1 – 25 von 26

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieBlood

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(22)
Mit Volltextzugriff
(22)

Publikationsform

Sprache

Englisch
(26)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Translational PK/PD and the first-in-human dose selection of a PD1/IL15: an engineered recombinant targeted cytokine for cancer immunotherapy

Hyperactive Ras in developmental disorders and cancer

Suppression of leukemia development caused by PTEN loss

Biochemical and Functional Characterization of Germ Line KRAS Mutations

714 PD1 x TGFβR2 bispecifics selectively block TGFβR2 on PD1-positive T cells, promote T cell activation, and elicit an anti-tumor response in solid tumors

Germline Mutations in Components of the Ras Signaling Pathway in Noonan Syndrome and Related Disorders

Deregulated Ras signaling in developmental disorders: new tricks for an old dog

Targeting the MYC and PI3K pathways eliminates leukemia-initiating cells in T-cell acute lymphoblastic leukemia

IL-15/IL-15Rα-Fc-Fusion Protein XmAb24306 Potentiates Activity of CD3 Bispecific Antibodies through Enhancing T-Cell Expansion

Germline KRAS mutations cause Noonan syndrome

Methods for PTEN in Stem Cells and Cancer Stem Cells

Abstract 5565: Potency-reduced IL15/IL15Rα heterodimeric Fc-fusions display enhanced in vivo activity through increased exposure

Abstract 3633: Anti-SSTR2 × anti-CD3 bispecific antibody induces potent killing of human tumor cells in vitro and in mice, and stimulates target-dependent T cell activation in monkeys: A potential immunotherapy for neuroendocrine tumors

Abstract 1639: Combination of PD1 blockade and T cell costimulation by bispecific antibodies promotes human T cell activation and proliferation

Abstract 2080: LAG3-targeted IL15/IL15Rα-Fc (LAG3 x IL15) fusion proteins for preferential TIL expansion

Abstract B12: Co-inhibition of PI3K and Myc pathways is synthetic lethal to PTEN null T-ALL leukemia-initiating cells

Hyperactive Ras in developmental disorders and cancer

Erratum: Hyperactive Ras in developmental disorders and cancer

Mutation analysis in Costello syndrome: functional and structural characterization of the HRAS p.Lys117Arg mutation

De novo HRAS and KRAS mutations in two siblings with short stature and neuro-cardio-facio-cutaneous features

Biochemical and functional analysis of Ras pathway mutations in myeloid leukemia and developmental disorders

Erratum: Corrigendum: Germline KRAS mutations cause Noonan syndrome

Corrigendum: Germline KRAS mutations cause Noonan syndrome

De novo HRAS and KRAS mutations in two siblings with short stature and neuro-cardio-facio-cutaneous features

Genotyping and drug response: use of single nucleotide polymorphisms (SNPs) versus haplotypes to predict albuterol efficacy

Aktive Filter

Suchergebnisse filtern